Literature DB >> 19946179

Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis.

Geom Seog Seo1, Jeong Kun Lee, Ji In Yu, Ki Jung Yun, Soo Cheon Chae, Suck Chei Choi.   

Abstract

Interferons play critical roles in tumor pathogenesis by controlling apoptosis and through cellular anti-proliferative and differentiation activities. Interferon inducible transmembrane protein (IFITM) family genes have been implicated in several cellular processes such as the homotypic cell adhesion functions of IFN and cellular anti-proliferative activities. Expression levels of IFITM genes have been found to be up-regulated in gastric cancer cells and colorectal tumors. IFITM3 (also known as 1-8U) is a member of the IFITM family, and has been described as a key player in specification of germ cell fate. IFITM3 was first isolated from a genetic screen aimed at identifying genes involved in acquisition of germ cell competence. It has been proposed that epiblast cells have the highest expression of IFITM3 initiated germ cell specification and that homotypic association can discriminate germ cells from their somatic neighbors. In an attempt to better understand the genetic influences of IFITM3 on ulcerative colitis, we have identified possible variation sites and single nucleotide polymorphisms (SNPs) through two exons and their boundary IFITM3 intron sequences including the approximately 2.1 kb promoter regions. To determine whether or not these IFITM3 SNPs are associated with susceptibility to ulcerative colitis, frequencies of the genotype and allele of IFITM3 polymorphisms were analyzed on genomic DNAs isolated from patients with ulcerative colitis and from healthy controls. We also investigated the haplotype frequencies constructed by these SNPs in both groups. In this study, we also showed that expression level of IFITM3 mRNA was significantly higher in tissues of the ileum and cecum of the digestive system. We identified a total of seven SNPs and multiple variation regions in the IFITM3 gene. The genotype frequency of the g.-204T>G polymorphism in patients with ulcerative colitis was significantly different from that of the control group. Our results strongly suggest that polymorphisms of the IFITM3 gene may be associated with susceptibility to ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19946179      PMCID: PMC2827834          DOI: 10.3858/emm.2010.42.2.011

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  30 in total

Review 1.  Clinical relevance of advances in genetics and pharmacogenetics of IBD.

Authors:  Tariq Ahmad; Cyrus Pesi Tamboli; Derek Jewell; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs.

Authors:  David A van Heel; Sheila A Fisher; Andrew Kirby; Mark J Daly; John D Rioux; Cathryn M Lewis
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Molecular analysis of a human interferon-inducible gene family.

Authors:  A R Lewin; L E Reid; M McMahon; G R Stark; I M Kerr
Journal:  Eur J Biochem       Date:  1991-07-15

5.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

6.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

7.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.

Authors:  R L Friedman; S P Manly; M McMahon; I M Kerr; G R Stark
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

8.  Molecular variations in Th1-specific cell surface gene Tim-3.

Authors:  Soo-Cheon Chae; Ju-Hee Song; Pann Pounsambath; Hai-Ying Yuan; Jae-Hoon Lee; Jeong-Joong Kim; Yong-Chul Lee; Hun-Taeg Chung
Journal:  Exp Mol Med       Date:  2004-06-30       Impact factor: 8.718

9.  Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway.

Authors:  S R Targan; R L Deem; M Liu; S Wang; A Nel
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

10.  The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice.

Authors:  U C Lange; M Saitou; P S Western; S C Barton; M A Surani
Journal:  BMC Dev Biol       Date:  2003-03-19       Impact factor: 1.978

View more
  13 in total

1.  IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.

Authors:  Chai Phei Gan; Kin Kit Sam; Pei San Yee; Nur Syafinaz Zainal; Bernard Kok Bang Lee; Zainal Ariff Abdul Rahman; Vyomesh Patel; Aik Choon Tan; Rosnah Binti Zain; Sok Ching Cheong
Journal:  Cell Oncol (Dordr)       Date:  2019-04-04       Impact factor: 6.730

2.  The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients.

Authors:  Sook-Kyoung Heo; Seong-A Ju; Gyu Yeol Kim; Sang-Min Park; Sung Hun Back; Neung-Hwa Park; Young Joo Min; Won G An; Thi Thu-Ha Nguyen; Sun-Min Kim; Byung-Sam Kim
Journal:  Exp Mol Med       Date:  2012-02-29       Impact factor: 8.718

Review 3.  IFITMs restrict the replication of multiple pathogenic viruses.

Authors:  Jill M Perreira; Christopher R Chin; Eric M Feeley; Abraham L Brass
Journal:  J Mol Biol       Date:  2013-09-25       Impact factor: 5.469

4.  Characterization and anti-inflammation role of swine IFITM3 gene.

Authors:  He-Ping Li; Pei-Ge Chen; Fu-Tao Liu; He-Shui Zhu; Xian-Qin Jiao; Kai Zhong; Yu-Jie Guo; Guang-Ming Zha; Li-Qiang Han; Wei-Fei Lu; Yue-Ying Wang; Guo-Yu Yang
Journal:  Oncotarget       Date:  2017-08-27

5.  Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma.

Authors:  Yuli Hou; Yonghong Zhang; Ling Qin; Chi Zhang; Shanshan Wang; Dexi Chen; Ang Li; Jinli Lou; Yanhua Yu; Tao Dong; Ning Li; Yan Zhao
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes.

Authors:  Samantha Lai-Yee Lau; Man-Leuk Yuen; Cecy Ying-Chuck Kou; Ka-Wing Au; Junwei Zhou; Stephen Kwok-Wing Tsui
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

7.  Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis.

Authors:  Ji-Su Mo; Kyung-Sook Na; Ji-In Yu; Soo-Cheon Chae
Journal:  Immunol Lett       Date:  2013-10-10       Impact factor: 3.685

8.  A functional promoter polymorphism of IFITM3 is associated with susceptibility to pediatric tuberculosis in Han Chinese population.

Authors:  Chen Shen; Xi-rong Wu; Wei-wei Jiao; Lin Sun; Wei-xing Feng; Jing Xiao; Qing Miao; Fang Liu; Qing-qin Yin; Chen-guang Zhang; Ya-jie Guo; A-dong Shen
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

9.  The role of IFITM3 in the growth and migration of human glioma cells.

Authors:  Bing Zhao; Hongliang Wang; Gang Zong; Ping Li
Journal:  BMC Neurol       Date:  2013-12-27       Impact factor: 2.474

10.  HIV-1 mutates to evade IFITM1 restriction.

Authors:  Shilei Ding; Qinghua Pan; Shan-Lu Liu; Chen Liang
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.